New tool pinpoints gaps in awareness of blood cancer symptoms
A new tool could help identify gaps in the public's knowledge of blood cancer symptoms—helping to shape future awareness campaigns that could save countless lives.
Jul 14, 2023
0
24
Immune System Diseases: News and Research on Multiple Myeloma
MeSH tree: C20.683.780.650
Outpatient stem cell transplants result in less hospitalization time for multiple myeloma patients, study finds
Most multiple myeloma patients undergoing stem cell transplants of their own cells can safely be treated in an outpatient setting, thus reducing costs, reducing hospitalization time and potentially increasing patient satisfaction, ...
Jul 5, 2023
0
28
RNA nanoparticle therapy stops the spread of incurable bone marrow cancer, study finds
Multiple myeloma is an incurable bone marrow cancer that kills over 100,000 people every year. Known for its quick and deadly spread, this disease is one of the most challenging to address. As these cancer cells move through ...
Jun 15, 2023
0
107
Study brings new understanding of multiple myeloma evolution
A new study by researchers at The University of Texas MD Anderson Cancer Center highlights novel insights into the evolution of multiple myeloma from precursor disease, which may help better identify patients likely to progress ...
Jun 12, 2023
0
60
Q&A: Thesis on new treatment approaches for multiple myeloma
Maria Karvouni from the Center for Hematology and Regenerative Medicine (HERM) at the Department of Medicine, Huddinge (MedH) is defending her thesis: "Cellular and personalized therapies in multiple myeloma with special ...
Jun 9, 2023
0
55
Treatment found to reduce progression of rare blood cancer by 74%
A treatment that involves genetically modifying the body's own immune cells has been found to cut the risk of disease progression by 74 percent in people with a rare type of blood cancer, results showed Monday.
Jun 5, 2023
0
37
CRISPR studies identify many promising therapeutic targets for multiple myeloma
New research from Dana-Farber Cancer Institute has identified 116 genes as key molecular vulnerabilities for multiple myeloma. Most of these genes are potential leads for the discovery of new therapies for this disease. The ...
May 29, 2023
0
94
New calculation tool identifies a group of cancer patients with favorable prognosis
Researchers at the Cima University of Navarra (Spain), in collaboration with the Spanish Myeloma Group (GEM-PETHEMA), have developed a calculator that identifies patients with multiple myeloma and primary systemic amyloidosis ...
May 4, 2023
0
49
Criteria for selecting who can enroll in multiple myeloma clinical trials may exclude patients from minority groups
Numerous studies have shown that people from racial and ethnic minority groups are underrepresented in clinical trials of new medical treatments for multiple myeloma. A study published today in the Blood Journal suggests ...
May 4, 2023
0
42
Testing hundreds of therapeutics outside the body to predict their effectiveness against multiple myeloma
Multiple myeloma is a rare blood cancer caused by the uncontrolled multiplication of abnormal plasma cells. These plasma cells are a special type of white blood cells that play an important role in the immune system by producing ...
Apr 27, 2023
0
74
